Literature DB >> 6130945

Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.

H Pouleur, M F Rousseau, P Mengeot, C Veriter, M F Vincent, L A Brasseur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6130945

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  11 in total

1.  Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.

Authors:  E Vigholt-Sørensen; O Faergeman
Journal:  Br Heart J       Date:  1990-09

Review 2.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 3.  Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  R Furlong; R N Brogden
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 4.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

5.  Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.

Authors:  E V Sorensen; B Sterndorff; M F Andersen; O Faergeman
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

6.  Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.

Authors:  E Vigholt-Sørensen; O Faergeman; H M Snow
Journal:  Br Heart J       Date:  1989-11

7.  Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.

Authors:  M Tangø; J E Carlsen; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.

Authors:  M G Collis; J R Keddie; W Rouse
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

9.  Haemodynamic effects of ICI 118,587 in cardiomyopathy.

Authors:  S Simonsen
Journal:  Br Heart J       Date:  1984-06

10.  The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease.

Authors:  A O Molajo; D H Bennett; H F Marlow; H M Snow; W Bastain
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.